Selected article for: "acute infection and Clara cell"
Author: Almuntashiri, Sultan; James, Chelsea; Wang, Xiaoyun; Siddiqui, Budder; Zhang, Duo
Title: The Potential of Lung Epithelium Specific Proteins as Biomarkers for COVID-19-Associated Lung Injury
  • Cord-id: ihnd27xc
  • Document date: 2021_9_8
    • ID: ihnd27xc
    Snippet: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was first reported in Wuhan, China, and was declared a pandemic by the World Health Organization (WHO) on 20 March 2020. The respiratory system is the major organ system affected by COVID-19. Numerous studies have found lung abnormalities in patients with COVID-19, including shortness of breath, respiratory failure, and acute respiratory distress syndrome. The identification of lung-specific biomarkers that are easily measura
    Document: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was first reported in Wuhan, China, and was declared a pandemic by the World Health Organization (WHO) on 20 March 2020. The respiratory system is the major organ system affected by COVID-19. Numerous studies have found lung abnormalities in patients with COVID-19, including shortness of breath, respiratory failure, and acute respiratory distress syndrome. The identification of lung-specific biomarkers that are easily measurable in serum would be valuable for both clinicians and patients with such conditions. This review is focused on the pneumoproteins and their potential to serve as biomarkers for COVID-19-associated lung injury, including Krebs von den Lungen-6 (KL-6), surfactant proteins (SP-A, SP-B, SP-C, SP-D), and Clara cell secretory protein (CC16). The current findings indicate the aforementioned pneumoproteins may reflect the severity of pulmonary manifestations and could serve as potential biomarkers in COVID-19-related lung injury.

    Search related documents:
    Co phrase search for related documents
    • accurate conclusion and additional study: 1, 2
    • accurate conclusion and lung abnormality: 1
    • accurate conclusion and lung development: 1
    • acute ards respiratory distress syndrome and additional study: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and long term impact: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung abnormality: 1, 2
    • acute ards respiratory distress syndrome and lung biomarker: 1, 2
    • acute ards respiratory distress syndrome and lung condition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute ards respiratory distress syndrome and lung development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and lung epithelium: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute ards respiratory distress syndrome and lung epithelium injury: 1, 2
    • acute condition and long term impact: 1
    • acute condition and lung condition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute condition and lung development: 1
    • acute lung injury and lung development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute lung injury and lung epithelium: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute lung injury and lung epithelium injury: 1, 2